Skip to content

Celcuity CELC Quick ratio

Quick ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.1×0.0×
Gilead Sciences logo
Gilead SciencesGILD
1.7×+0.5×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.1×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
22.1×+2.2×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
15.1×+10.0×
Tango Therapeutics logo
Tango TherapeuticsTNGX
27.4×+21.1×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's quick ratio?
Celcuity (CELC) reported quick ratio of 12.3× in Q1 2026.
How has Celcuity's quick ratio changed year-over-year?
Celcuity's quick ratio increased by 86.3% year-over-year, from 6.6× to 12.3×.
What is the long-term trend for Celcuity's quick ratio?
Over 5 years (2020 to 2025), Celcuity's quick ratio has grown at a 0.5% compound annual growth rate (CAGR), from 10.3× to 10.5×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.